A US federal appeals court has handed Apple a significant victory in its long-running legal dispute with AliveCor. Here are all the details.

The AliveCor Heart Monitor can be a cost-effective method to identify high risk of stroke in adults over 65 years old, according to a recent feasibility study published in the journal Thrombosis and ...

Apple this week secured another victory in its ongoing legal dispute with heart monitoring company AliveCor, after a federal ...

AliveCor’s latest attempt to revive its Apple Watch antitrust case fell short this week, with a federal appeals court ...

An antitrust lawsuit that AliveCor filed against Apple back in 2021 will not proceed, with the judge overseeing the case today filing a summary judgment in Apple's favor. The full ruling is under seal ...

Update: The story was updated with statements from Apple and AliveCor. A federal judge dismissed a lawsuit by startup AliveCor which accused Apple (NASDAQ:AAPL) of illegally monopolizing the U.S.

Japan-based medical device company Omron Healthcare has partnered with AliveCor to help bring AliveCor's FDA-cleared smartphone-connected electrocardiogram (ECG) to more online and brick and mortar ...

AliveCor is having a busy year. New deals and a recent study are positioning the San Francisco-based company closer to its goal of becoming a leader in consumerized healthcare. “Making money as we go ...

The U.S. Food and Drug Administration (FDA) has granted AliveCor clearance to sell technology that enables an iPhone or Android smartphone phone to record atrial fibrillation (AFib), the most common ...